Abstract
A liquid chromatography-electrospray ionization-tandem mass spectrometric (LC-ESI-MS/MS) method was developed and validated for the simultaneous detection and quantification of seven amphetamine derivatives (amphetamine (AP), methamphetamine (MA), 3,4-methylenedioxy-N-amphetamine (MDA), 3,4-methylenedioxy-N-methamphetamine (MDMA), 3,4-methylenedioxy-N-ethylamphetamine (MDEA), N,N-dimethylamphetamine (DMA), and N,N-dimethylamphetamine-N-oxide (DMANO)) in human urine. Seven deuterium-labeled compounds were prepared for use as internal standards to quantify the analytes. One milliliter of urine was combined with 1 mL of 0.2 M sodium carbonate buffer solution (pH 9.0) before solid phase extraction (SPE). An Oasis HLB SPE column followed by chromatographic separation on a Capcell Pak C18 MG-II column (150 × 2.0 mm I.D., 5 μm) and electrospray mass spectrometry with multiple reaction monitoring were used for selective and sensitive detection. The use of ammonium formate (5 mM, pH adjusted to 4.0 with formic acid, Solvent A) and acetonitrile (Solvent B) as the mobile phase at a flow rate of 230 μL/min was found to be the most effective for the separation. The linear ranges were 5.0–1000 ng/mL for AP, MDA, MDMA, MDEA, DMA, and DMANO and 10.0–1000 ng/mL for MA, with good correlation coefficients (r2 > 0.996). The intra-day, inter-day, and interperson precisions were within 14.6%, 12.1% and 15.5%, respectively. The intra-day, inter-day, and interperson accuracies were between −11.6 and 9.0%, −7.9 and 2.3%, and −13.2 and 4.3%, respectively. The limits of detection (LODs) for each analytical compound were lower than 1.95 ng/mL. The recovery ranged from 72.3 to 103.3%. The applicability of the developed method was examined by analyzing several urine samples from confirmed drug abusers.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andersson, M, Gustavsson, E, Stephanson, N, and Beck, O., Direct injection LC-MS/MS method for identification and quantification of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in urine drug testing. J. Chromatogr. B., 861, 22–28 (2008).
Bogusz, M. J., Liquid chromatography-mass spectrometry as a routine method in forensic sciences: a proof of maturity. J. Chromatogr. B., 748, 3–19 (2000).
Caldwell, J., The metabolism of amphetamines in mammals. Drug Metab. Rev., 5, 219–280 (1976).
Cheng, W. C., Mok, V. K., Chan, K. K., and Li, A. F., A rapid and convenient LC/MS method for routine identification of methamphetamine/dimethylamphetamine and their metabolites in urine. Forensic Sci. Int., 166, 1–7 (2007).
Cho, B. I., Methamphetamine abuse: epidemiologic issues and implications. In Miller, M. A. and Kozel, N. J. (Eds.). NIDA Research Monograph 115. US Department of Health and Human Services, Rockville, pp. 99–106 (1991).
Cody, J. T., Metabolic precursors to amphetamine and methamphetamine. Forensic Sci. Rev., 5, 109–127 (1993).
Fuh, M. -R., Wua, T. -Y., and Lina, T. -Y., Determination of amphetamine and methamphetamine in urine by solid phase extraction and ion-pair liquid chromatography-electrospray-tandem mass spectrometry. Talanta, 68, 987–991 (2006).
Glennon, R. A., Pharmacology and toxicology of amphetamine and related designer drugs. In Asghar, K. and De Souza, E. (Eds.). NIDA Research Monograph 94. US Department of Health and Human Services, Rockville, pp. 43–67 (1989).
Iio, R., Chinaka, S., Tanaka, S., Takayama, N., and Hayakawa, K., Simultaneous chiral determination of methamphetamine and its metabolites in urine by capillary electrophoresis-mass spectrometry. Analyst, 128, 646–650 (2003).
Inoue, T. and Suzuki, S., The metabolism of dimethylamphetamine in rat and man. Xenobiotica, 8, 965–971 (1987).
Jenner, P., The role of nitrogen oxidation in the excretion of drugs and foreign compounds. Xenobiotica, 1(4), 399–418 (1971).
Katagi, M., Tatsuno, M., Miki, A., Nishikawa, M., and Tsuchihashi, H., Discrimination of dimethylamphetamine and methamphetamine use: simultaneous determination of dimethylamphetamine-N-oxide and other metabolites in urine by high-performance liquid chromatography-electrospray ionization mass spectrometry. J. Anal. Toxicol., 24, 354–358 (2000).
Kim, J. Y., Jung, K. S., Kim, M. K., Lee, J. I., and In, M. K., Simultaneous determination of psychotropic phenylalkylamine derivatives in human hair by gas chromatography/mass spectrometry. Rapid Commun. Mass Spectrom., 21, 1705–1720 (2007).
Sato, M., Hida, M., and Nagase, H., Analysis of dimethylamphetamine and its metabolites in human urine by liquid chromatography-electrospray ionization-mass spectrometry with direct sample injection. Forensic Sci. Int., 128, 146–154 (2002).
Supreme Prosecutors’ Office, Drug Trend Report. vol. 12, Seoul, (2007).
Supreme Prosecutors’ Office, White Paper on Drug-Related Crimes. Seoul, pp. 95–122, (2004).
Witkin, J. M., Ricaurte, G. A., and Katz, J. L., Behavioral effects of N-methylamphetamine and N,N-dimethylamphetamine in rats and squirrel monkeys. J. Pharmacol. Exp. Ther., 253, 466–474 (1990).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, J.Y., Cheong, J.C., Ko, B.J. et al. Simultaneous determination of methamphetamine, 3,4-methylenedioxy-N-methylamphetamine, 3,4-methylenedioxy-N-ethylamphetamine, N,N-dimethylamphetamine, and their metabolites in urine by liquid chromatography-electrospray ionization-tandem mass spectrometry. Arch. Pharm. Res. 31, 1644–1651 (2008). https://doi.org/10.1007/s12272-001-2163-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-001-2163-5